GREAT POINT PARTNERS LLC Quant / Systematic

Location: Greenwich, CT

CIK: 0001281446 · Show all filings

Period: Q1 2014 (← Previous) (Next →)

Filing Date: May 15, 2014

Total Value: $191M (100.0% shares, 0.0% debt)

Holdings (36)

FURIEX PHARMACEUTICALS INC 9.4%
Value $17.91M Shares 205,858 Est. Cost $43.99 Unrealized
HYPERION THERAPEUTICS INC 6.7%
Value $12.74M Shares 493,751 Est. Cost $26.13 Unrealized
PAIN THERAPEUTICS INC 6.6%
Value $12.58M Shares 2,287,279 Est. Cost $2.72 Unrealized
ALIMERA SCIENCES INC 6.2%
Value $11.84M Shares 1,500,000 Est. Cost $7.89 Unrealized
DERMA SCIENCES INC 6.1%
Value $11.73M Shares 925,000 Est. Cost $12.68 Unrealized
OXYGEN BIOTHERAPEUTICS INC 5.8%
Value $11.1M Shares 2,000,000 Est. Cost $5.55 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 5.2%
Value $9.982M Shares 620,000 Est. Cost $17.10 Unrealized 0.0%
OM2 ORTHOFIX INTL N V 4.2%
Value $7.99M Shares 265,000 Est. Cost $30.15 Unrealized
OM2 ORTHOFIX INTL N V 3.9%
Value $7.538M Shares 250,000 Est. Cost $30.15 Unrealized
AMBIT BIOSCIENCES CORP 3.4%
Value $6.56M Shares 719,261 Est. Cost $15.50 Unrealized
INFIQ INFINITY PHARMACEUTICALS INC 3.1%
Value $5.95M Shares 500,400 Est. Cost $14.05 Unrealized -4.5%
VOLCANO CORPORATION 3.1%
Value $5.913M Shares 300,000 Est. Cost $22.13 Unrealized
ALCOBRA LTD 2.8%
Value $5.329M Shares 293,610 Est. Cost $18.02 Unrealized
VCYT VERACYTE INC 2.8%
Value $5.315M Shares 310,248 Est. Cost $13.01 Unrealized +22.7%
SOPHIRIS BIO INC 2.6%
Value $4.995M Shares 1,500,000 Est. Cost $4.51 Unrealized
ANTHERA PHARMACEUTICALS INC 2.4%
Value $4.587M Shares 1,369,237 Est. Cost $3.35 Unrealized
AVEO PHARMACEUTICALS INC 2.2%
Value $4.285M Shares 2,866,483 Est. Cost $1.83 Unrealized
RECRO PHARMA INC 2.2%
Value $4.246M Shares 580,000 Est. Cost $7.32 Unrealized
SUNSHINE HEART INC 2.2%
Value $4.246M Shares 727,000 Est. Cost $11.58 Unrealized
PROTALIX BIOTHERAPEUTICS INC 2.2%
Value $4.178M Shares 912,155 Est. Cost $4.15 Unrealized
CARA THERAPEUTICS INC 1.7%
Value $3.314M Shares 178,065 Est. Cost $18.61 Unrealized
OCERA THERAPEUTICS INC 1.7%
Value $3.29M Shares 311,821 Est. Cost $12.99 Unrealized
CYTK CYTOKINETICS INC 1.6%
Value $2.993M Shares 315,000 Est. Cost $9.04 Unrealized 0.0%
ONCOTHYREON INC 1.5%
Value $2.965M Shares 991,800 Est. Cost $2.99 Unrealized
NANOSPHERE INC 1.4%
Value $2.753M Shares 1,280,309 Est. Cost $2.00 Unrealized
DIPEXIUM PHARMACEUTICALS INC 1.3%
Value $2.52M Shares 250,000 Est. Cost $10.08 Unrealized
MANNKIND CORP 1.1%
Value $2.199M Shares 546,900 Est. Cost $4.02 Unrealized
MANNKIND CORP 1.1%
Value $2.119M Shares 527,000 Est. Cost $4.02 Unrealized
MEI PHARMA INC 0.9%
Value $1.755M Shares 157,661 Est. Cost $11.25 Unrealized
CHEMOCENTRYX INC 0.9%
Value $1.656M Shares 249,700 Est. Cost $5.79 Unrealized
ONCOGENEX PHARMACEUTICALS IN 0.8%
Value $1.529M Shares 130,000 Est. Cost Unrealized
KALOBIOS PHARMACEUTICALS INC 0.8%
Value $1.455M Shares 536,894 Est. Cost $2.71 Unrealized
SUNESIS PHARMACEUTICALS INC 0.7%
Value $1.279M Shares 193,567 Est. Cost $6.61 Unrealized
PSIVIDA CORP 0.6%
Value $1.162M Shares 283,313 Est. Cost $3.97 Unrealized
STREAMLINE HEALTH SOLUTIONS 0.4%
Value $763K Shares 151,611 Est. Cost $6.45 Unrealized
MOMENTA PHARMACEUTICALS INC 0.4%
Value $722K Shares 62,000 Est. Cost $11.65 Unrealized